ATC Group: M09AX14 Givinostat

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of M09AX14 in the ATC hierarchy

Level Code Title
1 M Musculo-skeletal system
2 M09 Other drugs for disorders of the musculo-skeletal system
3 M09A Other drugs for disorders of the musculo-skeletal system
4 M09AX Other drugs for disorders of the musculo-skeletal system
5 M09AX14

Active ingredients in M09AX14

Active Ingredient Description
Givinostat

Givinostat is a histone deacetylase inhibitor. The precise mechanism by which givinostat exerts its effect in patients with Duchenne muscular dystrophy (DMD) is unknown.

Related product monographs

Title Information Source Document Type  
DUVYZAT Oral suspension FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicines in this ATC group

United States (US)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.